Rajkumar, S.V.

(Vincent Rajkumar)

patient myeloma therapy response bortezomib dexamethasone study thalidomide blood trial university factor lenalidomide cancer treatment hospital serum regimen combination phase survival result group disease progression chain transplantation department cell transplantation hematology month mobilization high-dose light signi number transplant analysis protein thrombosis randomized table collection leukemia center chemotherapy cell collection cell mobilization marrow autologou bene ﬁt institute myeloma patients richardson g-csf mayo clinic cyclophosphamide incidence clinic rajkumar high-dose dexamethasone agent cycle risk factors journal diagnosis venou induction response rates meeting abstracts signi ﬁcantly assay medicine anderson effect prophylaxi erasmus mc venous thromboembolism ratio criteria

10 Most Recent Publications

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (Article) Kumar, S. Lee, J.H. Leleu, X. Hulin, C. Klein, S.K. Sonneveld, P. Siegel, D. Bladé, J. Goldschmidt, H. Jagannath, S. Miguel, J.S. Orlowski, R.Z. Lahuerta, J.J. Palumbo, A. Sezer, O. Rajkumar, S.V. Durie, B.G.M. Morgan, G. Richardson, P.G. Crowley, J. Haessler, J. Feather, J. Hoering, A. Moreau, P.	2012-01-01
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management (Article) Kyle, R. Durie, B.G.M. San Miguel, J-F. Avet-Loiseau, H. Hajek, R. Chen, W. Anderson, K.C. Ludwig, H. Sonneveld, P. Pavlovsky, S. Palumbo, A. Richardson, P.G. Rajkumar, S.V. Barlogie, B. Greipp, P. Vescio, R. Turesson, I. Westin, J. Boccadoro, M. Landgren, O. Bladé, J. Merlini, G. Kröger, N. Einsele, H. Vesole, D. Dimopoulos, M.A.	2010-04-22
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens (Article) Kumar, S. Giralt, S. Miguel, J.S. Ludwig, H. Bergsagel, L. Bladé, J. Lonial, S. Anderson, K.C. Tosi, P. Sonneveld, P. Sezer, O. Vesole, D. Stadtmauer, E.A. Cavo, M. Einsele, H. Richardson, P.G. Durie, B.G.M. Rajkumar, S.V. Harousseau, J-L. Palumbo, A. Bensinger, W. Comenzo, R.L. Lentzsch, S. Munshi, N.C. Niesvizky, R.	2009-11-20
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100) (Article) Giralt, S. Stadtmauer, E.A. Merlini, G. San Miguel, J. Ludwig, H. Hajek, R. Jagannath, S. Blade, J. Lonial, S. Dimopoulos, M.A. Einsele, H. Barlogie, B. Harousseau, J-L. Anderson, K.C. Gertz, M. Attal, M. Tosi, P. Sonneveld, P. Boccadoro, M. Morgan, G. Sezer, O. Mateos, M.V. Cavo, M. Palumbo, A. Joshua, D. Turesson, I. Chen, W. Shimizu, K. Powles, R. Richardson, P.G. Niesvizky, R. Rajkumar, S.V. Durie, B.G.M. Bensinger, W. Comenzo, R.L. Kumar, S. Munshi, N.C. Dispenzieri, A. Kyle, R.	2009-06-26
Front-Line Treatment in Younger Patients With Multiple Myeloma (Article) Rajkumar, S.V. Sonneveld, P.	2009-04-01
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders (Article) Dispenzieri, A. Kyle, R. Dimopoulos, M.A. Comenzo, R.L. Einsele, H. Barlogie, B. Anderson, K.C. Gertz, M. Harousseau, J-L. Attal, M. Tosi, P. Sonneveld, P. Merlini, G. Boccadoro, M. Morgan, G. Richardson, P.G. Sezer, O. Mateos, M.V. Cavo, M. Joshua, D. Turesson, I. Chen, W. Shimizu, K. Miguel, J.S. Powles, R. Rajkumar, S.V. Durie, B.G.M. Ludwig, H. Hajek, R. Palumbo, A. Jagannath, S. Bladé, J. Lonial, S.	2009-01-01
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping (Article) Johnson, D.C. Corthals, S.L. Jackson, G. Baris, D. Rajkumar, S.V. Davies, F. Durie, B.G.M. Crowley, J. Sonneveld, P. Ness, B. van Morgan, G. Ramos, C. Hoering, A. Cocks, K. Dickens, N.J. Haessler, J. Goldschmidt, H. Child, J.A. Bell, S.E.	2008-12-15
Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma (Article) Lonial, S. Richardson, P.G. Anderson, K.C. Harousseau, J-L. San Miguel, J-F. Sonneveld, P. Schuster, M.W. Bladé, J. Cavenagh, J. Rajkumar, S.V. Jakubowiak, A.J. Esseltine, D-L.	2008-10-01
The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma (Article) Niesvizky, R. Richardson, P.G. Harousseau, J-L. Boral, A.L. Esseltine, D-L. Anderson, K.C. Bladé, J. Rajkumar, S.V. Coleman, M. Rosiñol, L. Sonneveld, P. Schuster, M.W. Irwin, D. Stadtmauer, E.A. Facon, T.	2008-10-01
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma (Article) Palumbo, A. Rajkumar, S.V. Attal, M. Belch, A. Knop, S. Joshua, D. Sezer, O. Ludwig, H. Vesole, D. Bladé, J. Kyle, R. Westin, J. Dimopoulos, M.A. Weber, D. Bringhen, S. Niesvizky, R. Waage, A. Lilienfeld-Toal, M. Von Lonial, S. Morgan, G. Orlowski, R.Z. Shimizu, K. Anderson, K.C. Richardson, P.G. Boccadoro, M. Durie, B.G.M. Sonneveld, P. Hussein, M. San Miguel, J-F. Barlogie, B. Harousseau, J-L. Zonder, J.A. Cavo, M. Zangari, M.	2008-02-01

Message*:
Your Email Adress*:
	*: Required fields, please provide an email address so that the RePub team can contact you if needed.